Baxter International Inc. BAX
23.37
(0.11)
(0.47%)
as of 25 Sep
- Market cap
- $12.2B
- P/E
- 0.0×
Follow BAX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Baxter International Inc. (BAX) Total debt
Baxter International Inc.'s total debt at the end of fiscal 2025 was $9.5B, down 27.8% from $13.1B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $9.5B. Over the past ten years it has ranged from $2.8B (fiscal 2016) to $17.7B (fiscal 2021); the current reading is higher than 64% of that period. Baxter International Inc. ranks 3rd of 55 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $9.5B | (27.81%) |
| FY2024 | $13.1B | (4.58%) |
| FY2023 | $13.8B | (17.31%) |
| FY2022 | $16.6B | (5.80%) |
| FY2021 | $17.7B | 185.21% |
| FY2020 | $6.2B | 15.74% |
| FY2019 | $5.4B | 53.52% |
| FY2018 | $3.5B | (0.77%) |
| FY2017 | $3.5B | 26.24% |
| FY2016 | $2.8B | (57.25%) |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $9.5B | (0.04%) |
| Mar 2026 | $9.5B | (0.14%) |
| Dec 2025 | $9.5B | (0.27%) |
| Sep 2025 | $9.5B | 0.02% |
| 42 more quarters | Free account |
Against its own ten years
Low $2.8B
High $17.7B
Ten-year median
$6.5B
Current reading's percentile
64
Total debt against peers
| Company | Total debt |
|---|---|
| BAX Baxter International Inc. | $9.5B |
| SOLV Solventum Corporation compare | $5.3B |
| BLCO Bausch + Lomb Corporation compare | $5.1B |
| AVTR Avantor, Inc. compare | $3.7B |
| COO The Cooper Companies, Inc. compare | $2.5B |
| ATR AptarGroup, Inc. compare | $1.4B |
| RGEN Repligen Corporation compare | $551.0M |
| STVN Stevanato Group S.p.A. compare | $518.8M |
| ALGN Align Technology, Inc. compare | $127.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on BAX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement